280 assets in Pancreatic Ductal Adenocarcinoma

Immunoglobulin G4, Anti-(Human Programmed Cell Death Protein 1) (Human Monoclonal Regn2810 Heavy Chain), Disulfide With Human Monoclonal Regn2810 .Kappa.-Chain, Dimer

Licsbr

Neratinib

Pegph20

Ponatinib

Thymosins Thymalfasin

Zenocutuzumab

Ibentatug

Immuncell-Lc

Losartan

N-Butyl Cyanoacrylate

Sacituzumab Tirumotecan

Vismodegib

vs-7375

Abemaciclib

Certepetide

Fapi-46

FAPI74

hlx43

jyp0015

Pumitamig

Ssgj-706

S<Sup>3.15</Sup>,S<Sup>3.22</Sup>,S<Sup>3.29</Sup>-[(1,3,5-Triazinane-1,3,5-Triyl)Tris(3-Oxopropane-3,1-Diyl)]{N-[5-Oxo-5-({L-Valyl-N<Sup>5</Sup>-Carbamoyl-L-Ornithyl[(4-Aminophenyl)Methoxy]Carbonyl-N-Methyl-L-Valyl-Lvalyl-(3R,4S,5S)-3-Methoxy-5-Methyl-4-(Methylamino)Heptanoyl-(2R,3R)-N-[(1S,2R)-1-Hydroxy-1-Phenylpropan-2-Yl]-3-Methoxy-2-Methyl-3-[(2S)-Pyrrolidin-2-Yl]Propanamide}-N2.1-Yl)Pentanoyl]-?-Alanyldecakis(N-Methylglycyl)-L-Alanyl-N6-Carbamimidoyl-L-Lysyl-L-?-Aspartyl-L-Cysteinyl-(4R)-4-Hydroxy-L-Prolyl-L-Leucyl-L-Valyl-L-Asparaginyl-L-Prolyl-L-Leucyl-L-Cysteinyl-L-Leucyl-L-Histidyl-L-Prolyl-D-?-Aspartyl-L-Tryptophyl-N6-Carbamimidoyl-L-Lysyl-Lcysteinamide}

Toripalimab

YH-003 (HUMANIZED AGONISTIC ANTI-CD40 IGG2 MONOCLONAL ANTIBODY)

GEH300079 (68Ga)

Navlimetostat

ot-101

Paricalcitol

Rmc-9805

Tegafur

Eli-002 7P

Adenovirus 5/F35-Human Guanylyl Cyclase C-Padre

Aguix

azd0901

Cediranib

Daratumumab

Encorafenib

Enfortumab Vedotin (Fully Human Monoclonal Antibody Conjugated To A Cytotoxic Agent Monomethyl Auristatin E (Mmae) Targeting Nectin-4)

Eras-007

Escitalopram

Fludeoxyglucose

Glipizide

Glubran 2

Human Adenovirus C Serotype 5

KN510

KN713

Odetiglucan

ose2101

Palbociclib